"Huachao Shenkong" Secures 100 Million Yuan Angel Series Financing
Next-generation AI ultrasound brain-computer interface company Huachao Shenkong (BCI-Sonics) announced the completion of a 100 million yuan-level angel series financing. The angel round was led by Matrix Partners China, and the angel+ round was co-led by Delian Capital and Daoyuan Capital. The company was founded by Li Xin, a PhD from the Chinese Academy of Sciences and former head of GE Healthcare China, focusing on low-intensity focused ultrasound non-invasive brain-computer interface technology. The funds from this round will be used for technology validation and industrialization, advancing clinical translation for indications such as pain and addiction.
Next-generation AI ultrasound brain-computer interface company Huachao Shenkong (BCI-Sonics) announced the completion of a 100 million yuan-level angel series financing. The angel round was led by Matrix Partners China, and the angel+ round was co-led by Delian Capital and Daoyuan Capital. The company was founded by Li Xin, a PhD from the Chinese Academy of Sciences and former head of GE Healthcare China, focusing on low-intensity focused ultrasound non-invasive brain-computer interface technology. The funds from this round will be used for technology validation and industrialization, advancing clinical translation for indications such as pain and addiction.
This page provides an editorial summary based on publicly available information. It is not a republished article. Use the source link below for the original report.